Literature DB >> 94463

The humoral immune response to alpha, beta and gamma crystallins of the human lens.

H O Sandberg, O Closs.   

Abstract

By radioimmunoassay the occurrence of antibodies against alpha, beta and gamma crystallins was examined in sera from groups of patients with clear lenses, cataracts or lens injuries. In about half of the sera from each group low anti alpha crystallin activity was found. No significant difference in antibody activity was found between the groups. Antibody activity against beta or gamma crystallins was not detected in any of the sera. Four patients with lens damage were followed for 2 years; two of them developed uveitis and showed increasing anti alpha crystallin activity. It is suggested that in man immunological tolerance to lens crystallins is normally present.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94463     DOI: 10.1111/j.1365-3083.1979.tb01389.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

Review 1.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

2.  Antibodies to lens antigens in cataract and after cataract surgery.

Authors:  S H Nissen; P Andersen; H M Andersen
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

3.  Antilens antibodies in cataract and inflammatory eye disease: an evaluation of a new technique.

Authors:  M Patel; B Shine; P I Murray
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

4.  Characterization of anti-crystallin autoantibodies in patients with cataract.

Authors:  K B Merck; W A de Haard-Hoekman; J R Cruysberg; H Bloemendal; W W de Jong
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

5.  Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.

Authors:  Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-13       Impact factor: 3.535

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.